1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and PlatinumNeoplasms by Site, Thoracic Neoplasms, lung disorder, lung neoplasm, neoplasm, pulmonary large cell neuroendocrine carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 22024-08-02NCT06393816